Displaying 1 - 7 of 7 for Cancer - Hematology
  • ICare: Improving Care for Cancer Survivors (H-43629)
    • This study addresses the need to clarify system, provider and survivor-level facilitators of survivorship care plans implementation/use to guide future rollout efforts.
  • MOHEL Study (H-8701)
    • Subjects are being asked to participate in this study because treatment of their disease requires them to receive a stem cell transplant.
  • NCI MATCH Screening Trial (H-37222)
    • This clinical trial studies how well treatment directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists.
  • Primary Haemophagocytic Lymphohistiocytosis Study (H-33362)
    • The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytosis.
  • RELY-30 Study (H-37966)
    • In this study lymphodepletion chemotherapy will be administered in patients who are not post autologous transplant in the hope that it will result in more durable anti-tumor effects.
  • REMAIN Study (H-40203)
    • This trial studies how well nivolumab works in eliminating any remaining cancer cells and preventing cancer from returning in patients with acute myeloid leukemia who had a decrease in or disappearance of signs of cancer after receiving chemotherapy.
  • Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (H-36160)
    • The purpose of this study is to investigate the effects of sertraline in people with low-risk myelodysplastic syndrome (MDS).